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Abstract
Middle ear infection, otitis media (OM), is clinically important due to the high incidence in children and its impact on the
development of language and motor coordination. Previously, we have demonstrated that the human middle ear epithelial
cells up-regulate b-defensin 2, a model innate immune molecule, in response to nontypeable Haemophilus influenzae (NTHi),
the most common OM pathogen, via TLR2 signaling. NTHi does internalize into the epithelial cells, but its intracellular
trafficking and host responses to the internalized NTHi are poorly understood. Here we aimed to determine a role of
cytoplasmic pathogen recognition receptors in NTHi-induced b-defensin 2 regulation and NTHi clearance from the middle
ear. Notably, we observed that the internalized NTHi is able to exist freely in the cytoplasm of the human epithelial cells
after rupturing the surrounding membrane. The human middle ear epithelial cells inhibited NTHi-induced b-defensin 2
production by NOD2 silencing but augmented it by NOD2 over-expression. NTHi-induced b-defensin 2 up-regulation was
attenuated by cytochalasin D, an inhibitor of actin polymerization and was enhanced by a-hemolysin, a pore-forming toxin.
NOD2 silencing was found to block a-hemolysin-mediated enhancement of NTHi-induced b-defensin 2 up-regulation. NOD2
deficiency appeared to reduce inflammatory reactions in response to intratympanic inoculation of NTHi and inhibit NTHi
clearance from the middle ear. Taken together, our findings suggest that a cytoplasmic release of internalized NTHi is
involved in the pathogenesis of NTHi infections, and NOD2-mediated b-defensin 2 regulation contributes to the protection
against NTHi-induced otitis media.
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Introduction
The innate immune system constitutes the body’s first line of
defense against pathogens prior to activation of the adaptive
immune response [1]. It has become clear that secreted
antimicrobial innate immune molecules (AIIMs) such as defensins
play an essential role in the innate immune response to pathogens
[2]. Defensins are small cationic peptides that selectively form
multiple pores to the bacterial membrane, leading to a bactericidal
effect [3]. Particularly, b-defensins serve as a first line of defense in
the body surface because they are exclusively produced in the
keratinocytes and epithelial cells lining the respiratory, gastroin-
testinal and urinary tracts [2]. In our prior study, we showed that
b-defensin 2 (also known as DEFB4 or DEFB4A) is regulated by
IL-1 in the human middle ear epithelial cells [4]. We also
demonstrated that b-defensin 2 has a potent antimicrobial effect
on nontypeable Haemophilus influenzae (NTHi), an opportunistic
human pathogen [5] and is highly inducible by the NTHi
molecules [6,7].
NTHi is a small Gram-negative bacterium existing as a
commensal organism in the human nasopharynx [8] and forming
biofilms on human mucosal surfaces [9,10]. Unlike H. influenzae
type b, NTHi is nontypeable since it lacks a polysaccharide capsule
used for typing and rarely causes life-threatening infections [11].
Nonetheless, NTHi is a clinically important pathogen due to its
role in exacerbating chronic obstructive pulmonary disease in
adults and causing middle ear infection in children [12,13].
Middle ear infection, otitis media (OM), is one of the most
common pediatric infectious diseases accounting for 25% of
antibiotic prescriptions [14]. OM frequently leads to hearing
impairment (conductive and sensorineural) in children, impacting
their language development during the critical period [15,16].
Among the major OM pathogens, NTHi is becoming the most
common pathogen causing 35–56% of the OM cases due to a
pathogenic shift by the recent introduction of pneumococcal
vaccination [17,18].
NTHi is considered as an extracellular pathogen; however,
bacterial internalization (or invasion) into the epithelial cells is
suggested to contribute to the pathogenesis of NTHi infections
because they frequently persist despite antibiotic therapy and recur
after asymptomatic periods [19,20]. NTHi is known to enter host
cells through macropinocytosis initiated by cytoskeletal rearrange-
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ment [21] and endocytosis mediated by lipid raft or a receptor
[22–24]. After internalization, some pathogens are able to exist
freely in the cytoplasm after inhibition of the phagosomal
(endosomal) maturation [25,26], but intracellular trafficking of
NTHi is poorly understood [27].
Among a variety of pathogen recognition receptors (PRRs)
sensing pathogen-associated molecules, toll-like receptor 2 (TLR2),
a membrane-bound PRR, is known to be required for the
recognition of the NTHi molecules [28] even though NTHi is
Gram-negative. In addition to a variety of genes involved in
inflammation and ion homeostasis [29,30], the middle ear
epithelial cells were shown to up-regulate b-defensin 2 in response
to NTHi via TLR2 signaling [7]. NTHi is capable of entering the
epithelial cells, but our understanding about the role of
cytoplasmic PRR in NTHi-induced b-defensin 2 regulation
remains limited. Among the cytoplasmic PRRs, nucleotide-
binding oligomerization domain-containing proteins (NODs) are
involved in b-defensin 2 regulation [31,32] and NTHi-induced IL-
8 regulation [33]. Thus, we aimed to determine a role of NODs in
NTHi-induced b-defensin 2 regulation in the middle ear epithelial
cells and its involvement in protection of the middle ear from the
OM pathogens.
In this study, we present that internalized NTHi ruptures and
escapes from the surrounding membrane into the cytoplasm of the
human epithelial cells. Moreover, we show that NOD2 is involved
in recognition of the NTHi molecules and up-regulation of b-
defensin 2 in the middle ear epithelial cells. Modifications of the
epithelial cell membrane appeared to affect NOD2-dependent b-
defensin 2 regulation. We also demonstrate that NOD2 deficiency
significantly influences middle ear inflammatory reactions and
NTHi clearance from the middle ear cavity. This study will enable
us to better understand about intracellular trafficking of internal-
ized NTHi and host responses to NTHi in the cytoplasm of the
epithelial cells.
Materials and Methods
Ethics Statement
All animal experiments in this study were approved by the
Institutional Animal Care and Use Committee of the House
Research Institute, permitted protocol #HE1131-09-03.
Reagents
Cytochalasin D (CytD), a-hemolysin, and calcein AM were
purchased from Sigma-Aldrich (St. Louis, MO). siRNAs for
NOD1 (NM_006092: 59-GGCCAAAGUCUAUGAAGAUtt-39),
NOD2 (NM_022162: GGCUGAAAUUCAGAAUAUUtt-39),
TLR2 (NM_003264: 59-GCCUUGACCUGUCCAACAAtt-39),
NLRC4 (NM_021209: 59-GGUUCAAGCCAAAGUAUAAtt-39)
and RICK (NM_003821: 59-GGAGAAGAAUUUGCCAAAGtt-
39) were purchased from Life Technologies (Grand Island, NY).
Anti-Defb2, anti-NOD2, and anti-b-tubulin antibodies were
purchased from Santa Cruz Biotechnology (Dallas, TX).
Bacterial Culture and Preparation of Bacterial Lysate
NTHi 12 (provided by Dr. Xin-Xing Gu, NIH), originally a
clinical isolate from the middle ear fluid of a child with acute OM
[34], and GFP-conjugated NTHi 86-028NP (provided by Dr.
Lauren Bakaletz, Ohio State University) [35] were used in this
study. The bacteria were streaked onto fresh chocolate agar plate
and incubated overnight in a 37uC incubator with 5% CO2. A
single colony was grown in 3 ml of brain heart infusion broth
(BHI, Becton Dickinson, Cockeysville, MD), supplemented with
hemin (10 mg/ml) and NAD (10 mg/ml). NTHi lysate was
prepared as previously described [36]. Briefly, bacteria of a mid-
log phase (A600 = 0.4 to 0.5) were collected after centrifugation at
6,0006g for 30 min, and the bacterial pellet was resuspended in
5 ml of sterile water. After bacterial suspension was sonicated for
2 min in ice-water slurry, the samples were centrifuged at
12,0006g for 10 min at 4uC, and the supernatants were collected.
Protein concentrations of the NTHi lysates were determined using
a BCATM protein assay kit (Pierce Biotechnologies, Rockford, IL).
Animal Experiments and Primary Explant Culture
C57BL/6, TLR22/2 (C.129 (B6)-Tlr2tm1Kir) and NOD22/2
(B6.129S1-Nod2tm1Flv) mice were purchased from Jackson Labora-
tory (Bar Harbor, MA). TLR22/2NOD22/2 mice were gener-
ated by intercrossing of TLR22/2 and NOD22/2, and genotypes
were determined by PCR primers provided by Jackson Labora-
tory. All aspects of animal handling were performed according to
the approved Institutional Animal Care and Use Committee
(IACUC) guidelines. We induced an experimental OM as
described [37]. Briefly, animals were anesthetized with intraper-
itoneal injection of ketamine (80 mg/kg) and xylazine (10 mg/kg).
107 CFU of live NTHi in 5 ml of saline were transtympanically
inoculated to the middle ear cavity for histological analysis, and
300 CFU of NTHi, for bacterial clearance analysis. As a control,
5 ml of sterile normal saline was inoculated. Animals were
euthanized 24 h after injection, and the temporal bones were
dissected and embedded in paraffin for H & E staining and
immunolabeling as described [38] (Fig. S1). For bacterial
clearance analysis, we collected middle ear effusions, which were
cultured in the chocolate agar plates. For primary culture of
middle ear epithelial cells, 10 week-old male mice were euthanized
and decapitated. The bulla was isolated after sterile dissection, and
the bony capsule was carefully removed, preserving the middle ear
mucosa. Explants of the middle ear mucosa were plated onto the
collagen-coated culture dishes in DMEM (Life Technologies)
supplemented with 10% FBS.
Cell Culture
The human middle ear epithelial cell line (HMEEC) [39] was
maintained in a 1:1 mixture of DMEM and bronchial epithelial
basal medium (Lonza, Walkersville, MD) supplemented with
bovine pituitary extract (50 mg/ml), hydrocortisone (0.5 mg/ml),
hEGF (0.5 ng/ml), epinephrine (0.5 mg/ml), transferrin (10 mg/
ml), insulin (5 mg/ml), triiodothyronine (6.5 ng/ml), retinoic acid
(0.1 ng/ml), gentamicin (50 mg/ml), and amphotericin-B (50 ng/
ml). The Chang cells (the human conjunctival epithelial cell line,
CCL-20.2), Hela cells (the human cervical epithelial cell line,
CCL-2), and A549 cells (the human lung epithelial cell line, CCL-
185) were purchased from the ATCC (Manassas, VA) and
maintained in DMEM supplemented with 10% FBS. All cells
were cultured at 37uC in a humidified atmosphere with 5% CO2.
Gentamicin Protection Assay and Endocytosis Assay
To determine bacterial internalization, gentamicin protection
assays were performed as described [24]. Briefly, suspensions of
mid-log phase (A600 = 0.4 to 0.5) NTHi (2610
7 CFU/well) were
applied to 50% confluent monolayer of the HMEEC cells and the
Chang cells (26105 cells/well). After 4 h incubation, each well was
washed with PBS twice, and 100 mg/ml of gentamicin was added
for 2 h to remove the extracellular bacteria. To determine the
number of viable intracellular NTHi, all cells were harvested with
0.25% Trypsin-EDTA and were mechanically lysed by vigorous
vortexing with small glass pearls for 1 min. After plating the cell
lysate on chocolate agar plates, bacterial colonies were counted
after 24 h incubation. To determine internalized GFP-conjugated
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NTHi, fluorescent microscopy (Zeiss Axio Observer Z1 micro-
scope equipped with AxioVision image analyzer (Carl Zeiss,
Thornwood, NY)) was performed using cells grown onto a
coverslip and fixed with 4% para-formaldehyde solution. For
endocytosis assays, 0.5 mM of calcein AM was added to the
HMEEC cells after pretreatment of a-hemolysin (0.5,1.0 mg/ml).
After 2 h incubation, cells were washed with PBS and briefly lysed
with a NP-40 cell lysis buffer. After the lysates were transferred to a
96-well plate, fluorescence was measured at 490 nm/520 nm
using a plate reader.
Transmission Electron Microscopy
After co-cultured with NTHi for 4 h, cells were fixed for 1 h by
immersion in 2.5% glutaraldehyde in 100 mM cacodylate buffer
(pH 7.2), scraped, pelleted and processed using a microwave-
assisted method as previously described [40]. Epoxy resin-
embedded sections were examined and photographed with a
CM120 BioTwin transmission electron microscope (FEI, Inc.,
Hillsboro, OR), operating at 80 kVa. Images were recorded on
negative films and then digitized using a flat bed scanner. Images
were cropped for publication to emphasize relevant regions in the
cell and modifications of the scanned images consisted of adjusting
contrast and brightness. All adjustments were applied uniformly to
the whole image.
Quantitative RT-PCR
Quantitative RT-PCR analysis was performed using a FAMTM-
conjugated probe for b-defensin 2 and a VIC-conjugated probe
for cyclophilin with the ABI 7500 Real Time PCR System (Life
Technologies) as described [6]. The cycle threshold (CT) values
were determined according to the manufacturer’s instructions. CT
values were normalized to the internal control (cyclophilin), and
the relative quantity of mRNA was determined using the 22(DDCT)
method [41]. Taqman primers and probes for human b-defensin 2
(DEFB4, NM_004942, Hs00175474_m1), TLR2 (NM_003264,
Hs00152932_m1), NOD1 (NM_006092, Hs00196075_m1),
NOD2 (NM_022162, Hs00223394_m1) and cyclophilin
(NM_005729, 4326316E) were purchased from Life Technologies.
Primers used for conventional RT-PCR analysis were as follows:
18s rRNA (NR_003286: 59-GTGGAGCGATTTGTCTGGTT-
39; 59-CGCTGAGCCAGTCAGTGTAG-39), mouse Defb2
(NM_010030: 59-GCCATGAGGACTCTCTGCTC-39; 59-
GGACAAATGGCTCTGACACA-39), mouse Defb3
(NM_013756: 59-GTCATGAGGATCCATTACCTTCT-39; 59-
CGGGATCTTGGTCTTCTCTATTT-39), mouse Defb4
(NM_019728: 59- CTTGCAGCCTTTACCCAAATTAT-39; 59-
CTAGAACTGGAGTTAGAGAAGGTAATC-39), NLRC4
(NM_021209: 59-TGCCCAGAAATCGAAGCCCTGATA-39;
59-TTGGAGCAACAAGCCTTCAGCAAG-39), and RICK
(NM_003821: 59-TCCTGCATGAAATTGCCCTTGGTG-39;
59-ATCGTGCTTGATACTGGCCCTTGA-39).
ELISA
To measure protein levels of human b-defensin 2 produced by
the HMEEC cells, cells were transfected with the NOD2-specific
siRNA or the NOD2-expressing construct. Culture supernatants
were collected 24 h after exposure to the NTHi lysate. Protein
levels of human b-defensin 2 were quantified by ELISA according
to the manufacturer’s instructions (Phoenix Pharmaceuticals,
Burlingame, CA). Unknown concentrations of the samples were
determined by extrapolation to the standard curve of recombinant
human b-defensin 2, and data were expressed as pg/ml.
Plasmid Construction, Luciferase Assay and Gene
Silencing
Constructs used for luciferase assays were as follows:
pDEFB4/22625/luc containing the 59-flanking region (22625
to +1) of the human b-defensin 2 gene (AF071216) [4], pTAL-luc
containing the firefly luciferase gene with a TATA-like promoter
region from the Herpes simplex virus thymidine kinase promoter
(Clontech, Moutain View, CA), and pNFkB-luc containing
multiple copies of the NF-kB consensus sequence fused to
pTAL-luc (Clontech). The vector construct expressing human
NOD2 was provided by Dr. Neil Warner (University of Michigan).
Cells were transfected at ,60% confluency using the Transit-LT1
Transfection Reagent (Mirus, Madison, WI), and the pRL-TK
vector (Promega) was co-transfected for normalization of trans-
fection efficiency as described [42]. Transfected cells were then
starved overnight in serum-free DMEM, followed by exposure to
the NTHi lysate for 8 h before harvesting. All transfections were
carried out in triplicate. After lysing cells, luciferase activity was
measured using a luminometer (Pharmingen, La Jolla, CA) after
adding luciferase substrates (Promega). For gene silencing, gene-
specific siRNAs were transfected using a siPORT NeoFX
transfection agent (Ambion) according to the manufacturer’s
instruction. As a control, the negative control siRNA (Ambion) was
transfected in parallel. siRNA-mediated gene silencing was
confirmed by quantitative RT-PCR (Fig. S2).
Statistics
All experiments were carried out in triplicate and repeated
twice. Results were expressed as means 6 standard deviation.
Statistical analysis was performed using Student’s t-test and
ANOVA followed by Tukey’s post hoc test using the R2.14.0
software (The R Foundation for Statistical Computing, Vienna,
Austria). A value of p,0.05 was considered significant.
Results
Internalized NTHi Freely Exists in the Cytoplasm of the
Human Epithelial Cells
NTHi is capable of attaching to and entering a variety of
epithelial cells [43], which is initiated by cytoskeletal rearrange-
ment of the host cells [21,44]. To determine internalization of live
NTHi into the human epithelial cells, we performed gentamicin
protection assays. When 26105 of epithelial cells were exposed to
26107 cfu of live NTHi for 4 h, non-opsonic entry of NTHi
appeared at the rate of 4.2662.33 cfu per 103 of the HMEEC cells
and 35.26615.93 cfu per 103 of the Chang cells. After internal-
ization into the non-professional phagocytes including fibroblasts
and epithelial cells, some pathogens such as Listeria and Shigella are
known to escape from the membrane-bound compartment
(phagosome or endosome) into the nutrient-rich cytoplasm
[25,26,45]. To determine intracellular trafficking of internalized
NTHi, we performed transmission electron microscopy after
exposure of live NTHi to human epithelial cells such as the Chang
cells and HMEEC cells. Internalized NTHi was found to exist
either surrounded by an enclosing membrane or freely in the
cytoplasm of the Chang cells (Fig. 1A). Interestingly, we observed
NTHi in the process of being released into the cytoplasm after
rupturing the enclosing membrane (Fig. 1B). As shown in
Figure 1C and D, NTHi was found to exist with or without a
peribacterial space in the cytoplasm of the HMEEC cells. These
findings suggest that NTHi is able to compromise maturation of
phagosomes and that the cytoplasmic PRRs are required for the
recognition of the NTHi molecules in addition to the membrane-
bound PRRs such as TLR2 [7,46].
NOD2 Signaling by NTHi in Middle Ear Epithelium
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A Cytoplasmic Pathogen Recognition Receptor, NOD2 is
Involved in Recognition of NTHi
Among the membrane-bound PRRs, TLR2 plays a major role
for host’s recognition of the NTHi molecules [46,47]. In our prior
study, the HMEEC cells were shown to up-regulate human b-
defensin 2 in response to the NTHi lysate through the TLR2-
dependent signaling pathway [7], but we found that the TLR2-
deficient mice preserve the ability to up-regulate mouse Defb2 by
intratympanic injection of live NTHi. To determine if a TLR2-
independent pathway contributes to NTHi-induced mouse Defb2
up-regulation, the primary middle ear epithelial cells were derived
from the TLR2-deficient mice and were exposed to the NTHi
lysate. Conventional RT-PCR analysis showed that depletion of
TLR2 did not completely block NTHi-induced mouse Defb2 up-
regulation (Fig. S3A), suggesting the involvement of the TLR2-
independent signaling pathways. As a TLR2-independent path-
way, we further investigated cytoplasmic PRRs because NTHi
revealed the ability to freely exist in the cytoplasm. Based on the
reports showing the involvement of cytoplasmic PRRs such as
NOD1 and NOD2 in b-defensin 2 regulation induced by H. pylori
and muramyl dipeptide [31,32], we sought to determine if NOD1
and/or NOD2 contribute to NTHi-induced human b-defensin 2
up-regulation in the HMEEC cells. Since NOD1 recognizes
peptidoglycan-derived molecules from most Gram-negative bac-
teria [48] and is required for NTHi-induced IL-8 up-regulation
[33], we expected that NOD1 would be mainly responsible for
NTHi-induced human b-defensin 2 up-regulation. However,
quantitative RT-PCR analysis showed that NOD2-specific siRNA
inhibits NTHi-induced human b-defensin 2 up-regulation (,80%)
more than NOD1-specific siRNA (,50%) (Fig. 2A), indicating
that NOD2 is more significantly involved in NTHi-induced
human b-defensin 2 up-regulation in the HMEEC cells.
To further determine the requirement of NOD2 for NTHi-
induced human b-defensin 2 up-regulation, we performed ELISAs
for quantitation of human b-defensin 2 protein levels after
silencing or overexpressing of NOD2 in the HMEEC cells. As
shown in Figure 2B and 2C, siRNA-mediated inhibition of NOD2
expression appeared to suppress NTHi-induced human b-defensin
2 production (,55%) while overexpression of NOD2 was found to
augment human b-defensin 2 production (,45%). These findings
indicate the critical involvement of NOD2 in the human b-
defensin 2 production in response to the NTHi lysate, which plays
an important role for the antimicrobial defense in the HMEEC
cells. Next, we sought to determine how silencing of both TLR2
and NOD2 affects NTHi-induced human b-defensin 2 up-
regulation. Cells were transfected with either or both TLR2-
specific and NOD2-specific siRNAs and were exposed to the
NTHi lysate. Quantitative RT-PCR analysis showed that NTHi-
induced human b-defensin 2 up-regulation was completely
inhibited when both TLR2 and NOD2 were simultaneously
silenced (Fig. S3B), indicating that NOD2 signaling serves as a
TLR2-independent pathway for NTHi-induced human b-defensin
2 up-regulation.
NOD2-associated Molecules Contribute to NTHi-induced
b-defensin 2 Up-regulation
To determine the signaling pathway of NOD2 for NTHi-
induced human b-defensin 2 up-regulation, we sought to explore
the involvement of NOD2-associated signaling molecules such as
NLRC4 and RICK. It has been known that the NLRC4 (NLR
Family CARD Domain-Containing Protein 4), also known as
CARD12 (caspase recruitment domain-containing protein 12),
inhibits NOD2 activation through a NOD-NOD interaction [49].
RICK (RIPK2) is a CARD-containing serine/threonine kinase,
Figure 1. NTHi exists as a free or entrapped form after internalization into the human epithelial cells. (A) Transmission electron
microscopic image shows that NTHi is found either surrounded by an enclosing membrane (a) or free in the cytoplasm (b). (B) The membrane (arrow)
surrounding the bacterial cell is partially ruptured, and NTHi (arrowhead) appears to be in the process of being released into the cytoplasm of the
Chang cells. Scale bar for both images: 500 nm. (C, D) Note that NTHi (asterisks) exists with or without a peribacterial space (white arrows) in the
cytoplasm of the HMEEC cells. Scale bar for both images: 200 nm.
doi:10.1371/journal.pone.0090933.g001
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associated with NOD2 through CARD-CARD interactions [50].
Activation of RICK by virtue of binding to an activated NOD2
receptor leads to the activation of downstream IkK complex
through polyubiquitylation of IkKc. To determine if NLRC4
affects NTHi-induced human b-defensin 2 up-regulation,
NLRC4-specific siRNA was transfected to the HMEEC cells with
a luciferase-expressing vector containing a 59-flanking region of
DEFB4 (pDEFB4/22625/luc) as described previously [4]. As
shown in Figure 3A, luciferase assays showed that silencing of
NLRC4 enhances NTHi-induced human b-defensin 2 up-
regulation, indicating that NOD2-NLRC4 interaction interferes
with NOD2-mediated human b-defensin 2 up-regulation in
response to the NTHi lysate. In contrast, silencing of RICK was
found to inhibit NTHi-induced human b-defensin 2 up-regulation.
Next, we sought to determine if NOD2/RICK signaling affects
NTHi-induced NF-kB activation because NF-kB activation is
required for human b-defensin 2 regulation [51]. After silencing of
either NOD2 or RICK, we performed luciferase assays using
pNFkB-luc, a reporter construct of NF-kB activation. As shown in
Figure 3C, inhibition of NOD2 and RICK expression appeared to
significantly suppress NTHi-induced NF-kB activation. Altogeth-
er, these findings suggest that NOD2/RICK-dependent NF-kB
activation significantly contributes to human b-defensin 2 up-
regulation in response to the NTHi molecules in the cytoplasm of
the HMEEC cells.
Membrane Modification Affects NTHi-induced b-defensin
2 Up-regulation
Since cytoskeletal rearrangement is known to be required for
NTHi entry to human airway epithelial cells [21], we sought to
determine the involvement of actin polymerization in NTHi
internalization into the HMEEC cells. We performed gentamicin
protection assays after pretreatment with cytochalasin D (CytD),
an inhibitor of actin polymerization. As expected, the HMEEC
cells appeared to suppress NTHi internalization (,35% reduction)
upon exposure to CytD (Fig. 4A). Next, we performed quantitative
RT-PCR analysis after the HMEEC cells were exposed to the
lysate of NTHi to determine if inhibition of actin polymerization
affects NTHi-induced human b-defensin 2 up-regulation. As
shown in Figure 4B, CytD appeared to inhibit NTHi-induced
human b-defensin 2 up-regulation, indicating the involvement of
actin polymerization in NTHi-induced human b-defensin 2 up-
regulation in the HMEEC cells.
Bacterial pore-forming toxins are important virulent factors, but
there is controversy regarding to their effects on bacterial
internalization. For example, listeriolysin O mediates internaliza-
tion of L. monocytogenes into human hepatocytes [52] while a-
hemolysin interferes with integrin-mediated internalization S.
aureus [53]. To determine if pore formation affects NTHi
internalization into the HMEEC cells, we performed gentamicin
protection assays with GFP-conjugated NTHi after pretreatment
of the cells with a-hemolysin, a cholesterol-binding toxin. The
HMEEC cells were exposed to 500 ng/ml of a-hemolysin for 3 h,
which appeared to insignificantly affect cell viability (Fig. S4D, E).
Notably, a-hemolysin appeared to markedly augment NTHi
internalization into the HMEEC cells (Fig. 5A). a-Hemolysin-
mediated augmentation of NTHi internalization seemed to be
associated with actin polymerization (data not shown), but further
studies are needed to decipher the molecular mechanism involved.
Pneumolysin-induced pore formation is known to increase an
uptake of the NTHi molecules, resulting in enhancement of
NOD1-mediated signaling [33]. Consistently, endocytosis assays
showed that an intracellular influx of calcein AM increases ,30%
by a-hemolysin treatment (Fig. 5B). To further determine if a-
hemolysin affects NTHi-induced human b-defensin 2 up-regula-
tion, we performed quantitative RT-PCR analysis after pretreat-
ment with a-hemolysin. A suboptimal dose (1 mg/ml) of the NTHi
lysate insignificantly affected human b-defensin 2 regulation, but
a-hemolysin appeared to remarkably potentiate human b-defensin
2 up-regulation induced by a suboptimal dose of the NTHi lysate
(Fig. 5C). Furthermore, silencing of NOD2 expression was found
to inhibit a-hemolysin-mediated enhancement of NTHi-induced
human b-defensin 2 up-regulation (Fig. 5D), suggesting pore
formation enhances NOD2-mediated human b-defensin 2 up-
regulation in response to NTHi molecules. Altogether, these
findings indicate that membrane modification affects NOD2-
mediated human b-defensin 2 up-regulation through influencing
NTHi entry into the epithelial cells.
Figure 2. NOD2 contributes to NTHi-induced human b-defensin 2 up-regulation. (A) Quantitative RT-PCR analysis shows that NOD2-specific
siRNA inhibits NTHi lysate-induced human b-defensin 2 up-regulation more than NOD1-specific siRNA in the HMEEC cells. ELISA analysis shows that
NTHi lysate-induced human b-defensin 2 production is suppressed by the NOD2-specific siRNA (B) but is enhanced by NOD2 overexpression (C) in the
HMEEC cells. DEFB4: human b-defensin 2, NC: a control group silenced with a nonspecific negative control siRNA, KD: a group silenced with a gene-
specific siRNA, pcDNA: a mock transfection, hNOD2: a construct expressing human NOD2. Results were expressed as fold induction, taking the value
of the non-treated group as 1. The experiments were performed in triplicate and repeated twice. Values are given as the mean 6 standard deviation
(n = 3). *: p,0.05.
doi:10.1371/journal.pone.0090933.g002
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NOD2 Deficiency Delays NTHi Clearance from the Middle
Ear Cavity
Since we demonstrated a potent antimicrobial effect of human
b-defensin 2 on NTHi [5], we sought to determine if NOD2
deficiency influences the pathogenesis of middle ear infection. In
addition to our prior study showing that lysozyme deficiency
inhibits pneumococcal clearance from the middle ear cavity [37],
MyD88 deficiency is known to delay resolution of NTHi-induced
otitis media [54]. However, it is poorly understood how NOD2
deficiency affects middle ear inflammation and NTHi clearance
from the middle ear cavity. The primary mouse middle ear
epithelial cells derived from NOD2-deficient mice were exposed to
the NTHi lysate after overnight starvation. As shown in Figure 6A,
NOD2-deficient middle ear epithelial cells appeared to inhibit
mouse Defb2 up-regulation in response to the NTHi lysate,
compared to the wild type control. Next, we sought to determine if
NOD2 affects NTHi clearance from the middle ear after
intratympanic injection of live NTHi. The lavage of the mouse
middle ear cavity was collected 24 h after injection and was
cultured to count the number of live NTHi. As shown in Figure 6B,
live NTHi was hardly found in the middle ear cavity of the wild
Figure 3. Involvement of NLRC4 and RICK in NTHi-induced human b-defensin 2 up-regulation. (A) Luciferase assays show that NTHi
lysate-induced human b-defensin 2 up-regulation is enhanced by silencing of NLRC4 (a NOD2 inhibitor) but is inhibited by silencing of RICK that is
downstream to NOD2 in the HMEEC cells. NC: a control group transfected with a nonspecific siRNA, KD: a group transfected with a gene-specific
siRNA. (B) RT-PCR analysis showing siRNA-mediated inhibition of NLRC4 and RICK expression in the HMEEC cells. (C) Luciferase assays demonstrate
that NTHi lysate-induced NF-kB activation is inhibited by the siRNAs specific to NOD2 and RICK in the HMEEC cells. pTAL-luc: a control vector
containing the firefly luciferase gene with a TATA-like promoter region from the Herpes simplex virus thymidine kinase promoter, pNFkB-luc: a vector
containing multiple copies of the NF-kB consensus sequence fused to pTAL-luc, Tx: treatment. Results were expressed as fold-induction, taking the
value of the non-treated group as 1. The experiments were performed in triplicate and repeated twice. Values are given as the mean 6 standard
deviation (n = 3). *: p,0.05.
doi:10.1371/journal.pone.0090933.g003
Figure 4. Actin polymerization is involved in NTHi-induced human b-defensin 2 up-regulation. (A) Gentamicin protection assays show
that cytochalasin D (CytD), an inhibitor of actin polymerization, inhibits internalization of live NTHi into the HMEEC cells. (B) Quantitative RT-PCR
analysis shows that NTHi lysate-induced human b-defensin 2 up-regulation is suppressed by the treatment with CytD in the HMEEC cells. DEFB4:
human b-defensin 2. Results were expressed as fold-induction, taking the value of the non-treated group as 1. The experiments were performed in
triplicate and repeated twice. Values are given as the mean 6 standard deviation (n = 3). *: p,0.05.
doi:10.1371/journal.pone.0090933.g004
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type mice 24 h after intratympanic injection. In contrast,
intratympanic NTHi appeared to replicate 3-fold in the NOD2-
deficient mice and 10-fold in the NOD2/TLR2-deficient mice.
Histological analysis of the temporal bones was performed after
live NTHi was intratympanically injected into the mouse middle
ear cavity. Interestingly, H & E staining showed that middle ear
effusion and infiltration of inflammatory cells were less severe in
the NOD2-deficient mice than the wild type mice (Fig. 6C),
suggesting the involvement of NOD2 in recruitment of inflam-
matory cells, but further studies are necessary to reveal its
molecular mechanism. Taken together, these findings suggest that
NOD2 is critically involved in b-defensin 2 production in
recognition of cytoplasmic NTHi molecules, which may signifi-
cantly contribute to the antimicrobial defense of the middle ear as
a TLR2-independent pathway.
Discussion
In this study, we, for the first time, demonstrated the ability of
internalized NTHi to escape from the phagosome into the
cytoplasm of the human epithelial cells. We also showed that
NOD2, a cytoplasmic PRR, is critically involved in recognition of
the NTHi molecules, resulting in human b-defensin 2 up-
regulation in the HMEEC cells. Membrane modifications such
as actin polymerization and a-hemolysin-induced pore formation
were shown to influence NOD2-mediated human b-defensin 2
regulation through affecting NTHi entry. Moreover, in a mouse
model, we found that NOD2 deficiency attenuates middle ear
inflammatory reactions induced by intratympanic injection of live
NTHi and delays NTHi clearance from the middle ear cavity,
implying an essential role of NOD2 in antimicrobial defense of the
middle ear epithelium.
After internalization to the mammalian cells, pathogens are
known to usually reside in a membrane-bound compartment, a
phagosome (an endosome or a vacuole) [55]. Pathogens inside the
phagosome are subject to degradation in the process of
phagosomal maturation including acidification and proteolysis
by fusion with lysosomes [56,57]. However, some pathogens are
able to survive in the intracellular environment through blocking
phagosomal maturation [58,59] or escaping into the cytoplasm
[45]. Internalized NTHi was found within a membrane-bound
compartment, which is positive for endosomal antigens [60], but is
not colocalized with an autophagy marker, LC3 [22]. Our
electron microscopic images showed that internalized NTHi is
able to exist either freely in the cytoplasm or surrounded by the
membrane in the human epithelial cells. Surprisingly, we observed
NTHi in the process of being released into the cytoplasm after
rupturing the enclosing membrane. Phagosomal membranes are
disrupted by pore-forming toxins [61] and rapid delivery of low
pH [40], but further understanding how internalized NTHi
compromises phagosomal maturation awaits more studies.
Like TLRs, the leucine-rich repeat domains of NOD1 and
NOD2 enable the host to recognize bacterial molecules. NOD1,
also known as caspase recruitment domain-containing protein 4
(CARD4), recognizes the peptidoglycan-derived c-D-glutamyl-
meso-diaminopimelic acid from Gram-negative bacteria [48]. In
contrast, NOD2, also known as CARD15, recognizes peptidogly-
can-derived muramyl dipeptide (MDP) from both Gram-positive
and Gram-negative bacteria [62]. It is poorly understood how
these cytoplasmic PRRs are able to detect NTHi molecules from
the extracellular milieu. Cytoskeletal rearrangement is critically
involved in NTHi internalization into the respiratory epithelial
cells [21,44]. NTHi is also known to release outer membrane
vesicles during co-culture with host tissues, which directly interact
with host cell membrane [57]. Moreover, type IV secretion system
in H. pylori [63] and the membrane pore formation by a
cholesterol-binding toxin in S. pneumoniae [33] are known to be
involved in internalization of bacterial molecules. Consistently, our
result showed that membrane modifications affect NTHi inter-
nalization, leading to an influence on NOD2-mediated human b-
defensin 2 regulation.
NOD1 is known to be involved in H. influenzae-induced IL-8 up-
regulation in the respiratory epithelial cells [33]. Although NOD1
is the receptor that recognizes peptidoglycan-derived molecules
from most Gram-negative bacteria, we found that NOD2 is more
importantly involved in the recognition of NTHi molecules than
NOD1. We suggest that these findings agree with the requirement
of TLR2, not TLR4, for the recognition of NTHi even though
NTHi is Gram-negative [46,47]. NTHi is unique because it
contains only atypical lipooligosaccharide, not LPS (the common
Figure 5. Membrane pore formation enhances NOD2-dependent human b-defensin 2 up-regulation. (A) Fluorescent microscopic images
showing that a-hemolysin, a pore-forming toxin, enhances internalization of live NTHi (green) in the HMEEC cells. (B) An influx of calcein AM into the
HMEEC cells was increased by a-hemolysin. (C) Quantitative RT-PCR analysis shows that a-hemolysin markedly enhances human b-defensin 2 up-
regulation induced by a suboptimal dose (1 mg/ml) of NTHi lysate in the HMEEC cells. DEFB4: human b-defensin 2. (D) Note that silencing of NOD2
inhibits a-hemolysin-mediated enhancement of NTHi lysate-induced human b-defensin 2 up-regulation in the HMEEC cells. NC: a control group
transfected with a nonspecific siRNA, KD: a group transfected with a gene-specific siRNA. Results were expressed as fold-induction, taking the value of
the non-treated group as 1. The experiments were performed in triplicate and repeated twice. Values are given as the mean 6 standard deviation
(n = 3). *: p,0.05.
doi:10.1371/journal.pone.0090933.g005
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cell wall component of most Gram-negative enterobacteria). The
major ligand for NOD2 is MDP; however, considering that
NOD2 is able to interact with non-MDP ligands such as MurNAc-
L-Ala-c-D-Glu-L-Lys and sulfogalactoceramide [64,65], the
NTHi-derived NOD2-specific ligand remains to be identified.
In this study, we have used live NTHi for the experiments of
bacterial internalization and bacterial clearance from the middle
ear cavity because only live NTHi is able to invade host cells and
induce middle ear infections. However, the NTHi lysate has been
used for in vitro stimulation of the epithelial cells in this study
because (1) live NTHi was found to up-regulate human b-defensin
2 with high variations (Fig. S4B); and (2) the NTHi lysate appeared
to more significantly up-regulate human b-defensin 2 expression
than the same CFUs of live NTHi as shown in Fig. S4C. Although
bacterial lysates are not a perfect model, the NTHi lysate is
commonly used for the study of host-pathogen interactions as
shown in our prior studies [7,36,38,42] and other studies
[46,66,67] because live bacteria inhibit viability of mammalian
cells. Furthermore, it is suggested that the NTHi lysate is able to
up-regulate human b-defensin 2 expression more stably and
significantly than live NTHi since a variety of bacterial molecules
inside bacteria are able to directly access cytoplasmic PRRs after
bacterial lysis. [68].
Previously, we have demonstrated that AIIMs have a potent
bactericidal effect on the common OM pathogens such as NTHi
[5]. Among a diversity of the AIIMs, b-defensins are produced by
the mammalian epithelial cells lining the body surface [69].
Particularly, we selected b-defensin 2 as a model antimicrobial
peptide because it effectively kills Gram-negative pathogens and is
highly inducible in response to challenging pathogens [2]. Multiple
signaling pathways are known to orchestrate the regulation of b-
defensin 2, including toll/IL-1 receptor (TIR)-dependent NF-kB
activation [70], IL-17-dependent JAK signaling [71] and protease-
activated receptor 2 (PAR2)-dependent NF-kB activation [72]. In
our prior studies, we showed that the human middle ear epithelial
cells up-regulate human b-defensin 2 in response to IL-1 and
NTHi lysate via Src/ERK signaling [4] and TLR2/MyD88
signaling [7], in addition to the synergistic effect of IL-1 and NTHi
lysate [6]. NOD1 and NOD2 are also known to be involved in b-
defensin 2 regulation induced by H. pylori and MDP, respectively
[31,32]. In this study, we found that NOD2 signaling importantly
contributes to NTHi-induced human b-defensin 2 regulation as a
TLR2-independent pathway. Although NOD2, in the absence of
MDP, is known to negatively regulate TLR4 signaling [73],
NOD2 and TLR2 signaling are suggested to be non-redundant to
each other for the NTHi recognition because NODs signaling is
rather enhanced by the up-regulation of RICK when TLRs
signaling is refractory to TLR agonists [74]. Moreover, NOD2
signaling is tightly regulated to avoid over-stimulation. For
example, peptidoglycan-activated NLRC4 interferes with the
activation of NOD2, functioning as a negative feedback [49].
Consistently, our results showed that inhibition of NLRC4
Figure 6. NOD2 is involved in bacterial clearance from the mouse middle ear. (A) Quantitative RT-PCR analysis shows that NOD2-deficient
middle ear epithelial cells less up-regulate mouse Defb2 in response to the NTHi molecules, compared to the wild type cells. Values are given as the
mean 6 standard deviation (n = 3). *: p,0.05. (B) Bacterial clearance analysis shows that the number of survived NTHi after intratympanic injection is
higher in the NOD2-deficient mice compared to the wild type mice. It is noted that intratympanic NTHi replicates 10-fold in the NOD2/TLR2-deficient
mice (NOD22/2TL22/2). Values are given as the mean 6 standard deviation (n = 20). (C) Histological analysis shows that middle ear inflammation in
response to intratympanic injected NTHi is less severe in the NOD2-deficient mice (NOD22/2) than that in the wild type mice (WT). Arrowheads:
middle ear effusion with infiltration of inflammatory cells, M: middle ear cavity, Co: cochlea. Original magnification: x50.
doi:10.1371/journal.pone.0090933.g006
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enhances NTHi-induced human b-defensin 2 up-regulation,
suggesting that NLRC4 serves as a negative regulator for human
b-defensin 2 production because high levels of human b-defensin 2
are rather cytotoxic to host cells [75].
In addition to susceptibility to Crohn’s disease and Blau
syndrome [76], NOD2 polymorphisms are associated with
susceptibility to mycobacterial infections [77,78]. NOD2-deficient
mice are also known to be susceptible to E. coli-induced lung
infection [79] and exhibit impaired intestinal clearance of
Citrobacter [80]. In contrast, NOD2 deficiency insignificantly
affected immune reactions to Y. enterocolitica [81] and paradoxically
made mice resistant to Ehrlichia infection due to an increase in IL-
10 expression and a decrease in CD8+ T cells [82]. Since NTHi is
not frequently internalized into the middle ear epithelial cells
in vitro, we expected that NOD2 deficiency rarely influences
bacterial clearance from the middle ear. On the contrary to our
expectation, NOD2 deficiency was revealed to significantly impact
middle ear inflammatory reactions and NTHi clearance from the
middle ear, which agrees with the reports that NTHi internali-
zation is associated with intractable acute OM [83] and that
NOD2 expression is up-regulated in the middle ear mucosa of the
patients with chronic OM [84]. Our findings indicate that NTHi
internalization and NOD2 signaling are significantly involved in
the pathogenesis of experimental OM, but further studies are
needed to determine an association of NOD2 polymorphisms with
recurrence and chronicity of NTHi infections.
Recently, HUGO Gene Nomenclature Committee (HGNC)
has changed the official gene name of human b-defensin 2 from
DEFB4 to DEFB4A. Moreover, there exists controversy in a
murine ortholog of DEFB4A (www.genecards.org/cgi-bin/
carddisp.pl?gene =DEFB4A&ortholog = all#orthologs; www.
informatics.jax.org/marker/MGI:1338754). In this study, the
Defb2 gene has been used as a mouse model of the human b-
defensin 2 gene because it is inducible in response to pro-
inflammatory stimuli [85], but Defb2 may not reflect the ortholog
of DEFB4A. Defb3 [86] and Defb4 [87] seem to be closer to the
murine ortholog of DEFB4 since they share more than 40%
identical peptides with DEFB4A; however, the real murine
ortholog of DEFB4 still remains controversial. As expected, Defb4
was up-regulated in response to the NTHi lysate in the middle ear
epithelial cells derived from the wild type mice (Fig. S4A).
Moreover, NOD2 deficiency appeared to inhibit NTHi-induced
up-regulation of Defb4, which may contribute to delayed bacterial
clearance from the middle ear in NOD2-deficient mice. Unex-
pectedly, Defb3 was insignificantly expressed in the murine middle
ear epithelial cells (data not shown), but further studies are
necessary to determine a role of the DEFB4 ortholog in
experimental OM.
In conclusion, the present study has revealed the ability of
NTHi to escape from the phagosome to the epithelial cytoplasm,
which may importantly contribute to the pathogenesis of NTHi-
induced OM. To defend intracellular NTHi, the middle ear
epithelial cells are suggested to be capable of recognizing the
NTHi molecules inside the cytoplasm via a NOD2/RICK-
dependent signaling pathway, resulting in the induction of
antimicrobial molecules. We are only at the beginning of our
understanding of the molecular mechanism involved in NTHi
internalization and host response, but this study will provide us
with a scientific basis for a new therapeutic strategy to manage
NTHi infectious diseases.
Supporting Information
Figure S1 NTHi induces b-Defensin 2 up-regulation in
the middle ear epithelial cells. (A) An inferior view of the
mouse skull base shows that the anatomic relationship of the bulla
and Eustachian tube. HP: hard palate, UT: upper teeth, Bu: bulla,
FM: foramen magnum, An: anterior, R: right. (B) Schematic
illustration of tubotympanum. PO: pharyngeal orifice of Eu-
stachian tube, TO: tympanic orifice of Eustachian tube, TM:
tympanic membrane, EAC: external auditory canal, #: the
mucosal area nears the tubal orifice for immunolabeling. (C)
Immunolabeling shows increased production of mouse Defb2
upon exposure to live NTHi with infiltration of inflammatory cells
and mucosal edema. Con: a saline-treated control, ME: middle ear
mucosa, TB: temporal bone. Original magnification: x200. (D)
Quantitative RT-PCR analysis shows that the NTHi lysate up-
regulates human b-defensin 2 in a time dependent manner in the
HMEEC cells. E) Luciferase assays show that the NTHi lysate up-
regulates human b-defensin 2 expression in the human epithelial
cell lines such as the HMEEC cells, the A549 cells and the HeLa
cells. DEFB4: human b-defensin 2, Tx: treatment. Results were
expressed as fold-induction, taking the value of the non-treated
group as 1. Values are given as the mean 6 standard deviation
(n= 3). *: p,0.05.
(DOCX)
Figure S2 siRNA-mediated silencing of NOD1, NOD2
and TLR2. Quantitative RT-PCR analysis (A, B) and immuno-
precipitation (C) are showing siRNA-mediated silencing of NOD1,
NOD2 and TLR2 in the HMEEC cells. NC: a control group
silenced with a nonspecific negative control siRNA, KD: a group
silenced with a gene-specific siRNA, Double KD: simultaneous
silencing of NOD2 and TLR2, IP: immunoprecipitation, WB:
western blotting.
(DOCX)
Figure S3 TLR2 and NOD2 are required for NTHi-
induced human b-defensin 2 up-regulation. (A) RT-PCR
analysis shows that TLR2 deficiency (TLR22/2) does not
completely block NTHi lysate-induced mouse Defb2 up-regulation
in the mouse middle ear epithelial cells. WT: wild type, 18s: 18s
rRNA. (B) NTHi lysate-induced human b-defensin 2 up-
regulation is blocked when both TLR2 and NOD2 are
simultaneously silenced in the HMEEC cells. NC: a control group
silenced with a nonspecific negative control siRNA, KD: a group
silenced with a gene-specific siRNA.
(DOCX)
Figure S4 (A) RT-PCR analysis shows that mouse Defb4 is up-
regulated in response to the NTHi lysate in the primary middle ear
epithelial cells derived from wild type mice (WT). In contrast, it is
noted that NOD2 deficiency (NOD22/2) inhibits NTHi-induced
up-regulation of Defb4. 18s: 18s rRNA. (B) Quantitative RT-PCR
analysis shows that the HMEEC cells up-regulate human b-
defensin 2 expression in response to live NTHi in a dose-
dependent manner, which fails to show a statistical significance
due to a high variance. (C) Note that human b-defensin 2 is up-
regulated by the lysate (5.7561.25 mg/ml) extracted from 56107
CFU of NTHi more significantly than the same CFUs of live
NTHi. *: p,0.05. MTT assays (D) and MultiTox-GloTM
Multiplex Cytotoxicity Assays (Promega) (E) show that the viability
of the HMEEC cells is not affected by exposure of 500 ng/ml of a-
hemolysin for 5 h. *: p,0.05.
(DOCX)
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